Frontiers in Immunology (Jan 2018)

Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis

  • Rebecca A. Marsh

DOI
https://doi.org/10.3389/fimmu.2017.01902
Journal volume & issue
Vol. 8

Abstract

Read online

Epstein–Barr virus (EBV) is a ubiquitous virus that infects nearly all people worldwide without serious sequela. However, for patients who have genetic diseases which predispose them to the development of hemophagocytic lymphohistiocytosis (HLH), EBV infection is a life-threatening problem. As a part of a themed collection of articles on EBV infection and human primary immune deficiencies, we will review key concepts related to the understanding and treatment of HLH.

Keywords